Use of HIV-1 pol gene precursor to detect HIV-1 and HIV-2

[Institutional delivery rate in minority inhabited areas of China from 1996 to 2017].

Zhonghua yi xue za zhi·2019

[HIV epidemic among pregnant women in China, 2016: trend and spatial analysis].

Zhonghua yi xue za zhi·2018

[Secular trends of institutional delivery rate in China from 1996 to 2015].

Zhonghua yi xue za zhi·2017

High prevalence of occult hepatitis B among immigrant students in Canada: A case for universal immunization of young adults.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012

How good are we at advising appropriate patients with glaucoma to inform the DVLA? A closed audit loop.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2008

Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2005

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Medical Device Recalls in Neurosurgery: A United States Regulatory Analysis.

Neurosurgery practice·2026

Predictive biomarkers of biologic therapy response in chronic rhinosinusitis with nasal polyps: a systematic review.

Frontiers in medicine·2026

Llama mRNA-LNP immunization enables rapid isolation of target specific nanobodies using cell-based panning.

Antibody therapeutics·2026

An IgG-like fusion protein comprising an anti-spike S2 antibody and ACE2 exhibits potent and broad neutralization against SARS-CoV-2 and variants of concern.

Antibody therapeutics·2026

A landscape of sequence variants in 51 commercial antibody therapeutics.

Antibody therapeutics·2026

Evaluating plasma ferritin and suPAR as treatable traits for critically ill patients with COVID-19 treated with anakinra: an exploratory analysis of the immune modulation domain of the REMAP-CAP randomised clinical trial.

Critical care (London, England)·2026

Related Experiment Videos

Use of HIV-1 pol gene precursor to detect HIV-1 and HIV-2

Related Concept Videos

[Institutional delivery rate in minority inhabited areas of China from 1996 to 2017].

[HIV epidemic among pregnant women in China, 2016: trend and spatial analysis].

[Secular trends of institutional delivery rate in China from 1996 to 2015].

High prevalence of occult hepatitis B among immigrant students in Canada: A case for universal immunization of young adults.

How good are we at advising appropriate patients with glaucoma to inform the DVLA? A closed audit loop.

Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Medical Device Recalls in Neurosurgery: A United States Regulatory Analysis.

Predictive biomarkers of biologic therapy response in chronic rhinosinusitis with nasal polyps: a systematic review.

Llama mRNA-LNP immunization enables rapid isolation of target specific nanobodies using cell-based panning.

An IgG-like fusion protein comprising an anti-spike S2 antibody and ACE2 exhibits potent and broad neutralization against SARS-CoV-2 and variants of concern.

A landscape of sequence variants in 51 commercial antibody therapeutics.

Evaluating plasma ferritin and suPAR as treatable traits for critically ill patients with COVID-19 treated with anakinra: an exploratory analysis of the immune modulation domain of the REMAP-CAP randomised clinical trial.

Related Experiment Videos

Use of HIV-1 pol gene precursor to detect HIV-1 and HIV-2

Related Concept Videos

Related Articles